Does Dr. KIMBERLY BADESSA have financial conflicts of interest?

Dr. KIMBERLY BADESSA (APRN) has received a total of $345 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $345 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. KIMBERLY BADESSA?

According to CMS Open Payments data, Dr. KIMBERLY BADESSA received funding from EDWARDS LIFESCIENCES CORPORATION ($211), ASTELLAS PHARMA US ($115), and TELIX PHARMACEUTICALS ($20).

Does Dr. KIMBERLY BADESSA receive research grants or speaking fees?

Dr. KIMBERLY BADESSA has received $345 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. KIMBERLY BADESSA

APRNReal-Time Hydrated

Specialty: Nurse Practitioner, Family

Practice Location: NASHUA, NH 03060

NPI Number: 1750769469

LIFETIME INDUSTRY VALUE

$345

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BADESSA is a verified Nurse Practitioner, Family practitioner based in NASHUA, NH.

Between 2021 and 2025, Dr. BADESSA had an overall industry promotional and research financial footprint of $345 as recorded in the federal CMS Open Payments database.

$345 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BADESSA's primary funding source is EDWARDS LIFESCIENCES CORPORATION, which accounts for $211 (representing 61.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

EDWARDS LIFESCIENCES CORPORATION

Rank 1

$211

61.1%

ASTELLAS PHARMA US

Rank 2

$115

33.2%

TELIX PHARMACEUTICALS

Rank 3

$20

5.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.